Amelioration of Alloxan Induced Diabetes mellitus and Oxidative Stress in Rats by Oil of Eruca sativa SeedsEl-Missiry M.A.a · El Gindy A.M.b
Zoology Departments, Faculties of Science,aMansura University, Mansura, and bAl Azhar University, Cairo, Egypt
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Clinical research has confirmed the efficacy of several plant extracts in the modulation of oxidative stress associated with diabetes mellitus (DM). Oil of Eruca sativa seeds (ESS) is tried for prevention and treatment of DM induced experimentally by alloxan injection. A single dose of alloxan (100 mg/kg) produced a decrease in insulin level, hyperglycemia, elevated total lipids, triglycerides and cholesterol, decreased high-density lipoprotein and hepatic glycogen contents and elevated hepatic glucose-6-phosphatase activity. Concurrent with these changes, there was an increase in the concentration of malondialdehyde and 4-hydroxynonenal in the liver. This oxidative stress was related to a decreased glutathione (GSH) content and superoxide dismutase activity in the liver of alloxan-diabetic rats. ESS oil (0.06 ml/kg) on its own increased significantly hepatic GSH. Daily oral administration of ESS oil 2 weeks before or after diabetes induction ameliorated hyperglycemia, improved lipid profile, blunted the increase in malondialdehyde and 4-hydroxynonenal and stimulated the GSH production in the liver of alloxan-treated rats. We suggested that ESS oil could be used as antidiabetic complement in case of DM. This may be related to its antioxidative properties and to the increase in hepatic GSH.
© 2000 S. Karger AG, Basel
- Oberley LW: Free radicals and diabetes. Free Radic Biol Med 1988;5:113–124.
- Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405–412.
- Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257–267.
- Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997;27:484–490.
Stefano AS, Marra G, Giardina B, Cotroneo P, Mordent A, Martorana GE, Manto A, Ghirlanda G: Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997; 46:1853–1858.
- Fahey JW, Talalay P: Antioxidant functions of sulforaphane: A potent inducer of phase II detoxicating enzymes. Food Chem Toxicol 1999;37:973–979.
- Iori R, Bernardi R, Gueyrard D, Rollin P, Palmieri S: Formation of glucoraphanin by chemoselective oxidation of natural glucoerucin: A chemoenzymatic route to sulforaphane. Bioorg Med Chem Lett 1999;9:1047–1048.
Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T: Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets: H2O2 as mediator for DNA fragmentation. Diabetes 1991; 40:1141–1145.
Nicholas VC, Robert WL, Joseph HR: The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 1956;220:583–593.
Swanson MA: Glucose-6-phosphatase from liver. Methods Enzymol 1956,2:541–543.
Nishikimi M, Rao NA, Yagl K: The occurrence of superoxide anion in the reaction of reduced phenazine methosulphate and molecular oxygen. Biochem Biophys Res Commun 1972;46:844–853.
Beutler E: Red Cell Metabolism: A Manual of Biochemical Methods, ed 3. New York, Grune & Stratton, 1982, pp 37–40.
Akhtar MS, Ali MR: The study of hypoglycemic activity of Cuminum nigrum seeds in normal and alloxan diabetic rabbits. Planta Med 1984;2:81–85.
Fayed T, El-Missiry MA, Emara H, El Sayaad N: Effect of Nigella sativa or fish oil supplementation in alloxan diabetic rats. J Union Arab Biol 1998;9:237–250.
- Shanmugasundaram ER, Gopianth KL, Radha SK, Rajendram VM: Possible regeneration of the islets of Langerhans in streptozotocin diabetic rats given Gymnema sylvestra leaf extracts. J Ethnopharmacol 1990;30:265–279.
- Soto CP, Perez BL, Favari LP, Reyes JL: Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998;119:125–129.
El-Missiry MA: Enhanced testicular antioxidant system by ascorbic acid in alloxan diabetic rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999;124: 233–237.
- Esterbauner H, Schaur RJ, Zöllner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
- Grune T, Siems WG, Petras T: Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal in in situ perfused rat kidney. J Lipid Res 1997;38:1660–1665.
- Gerhauser C, You M, Liu J, Moriarty RM, Hawthorne M, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 1997;57:272–278.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.